No Data
No Data
Nurix Therapeutics (NRIX) Surges 20.6%: Is This an Indication of Further Gains?
Express News | Nurix Therapeutics Shares Are Trading Higher After HC Wainwright & Co. Maintained a Buy Rating and Raised Its Price Target From $19 to $26
Nvidia To Rally Around 53%? Here Are 10 Top Analyst Forecasts For Tuesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.BMO Capital
Nurix Therapeutics Is Maintained at Buy by HC Wainwright & Co.
Nurix Therapeutics Is Maintained at Buy by HC Wainwright & Co.
Express News | Nurix Therapeutics, Inc. : H.c. Wainwright Raises Target Price to $26 From $19
HC Wainwright & Co. Maintains Buy on Nurix Therapeutics, Raises Price Target to $26
HC Wainwright & Co. analyst Robert Burns maintains Nurix Therapeutics (NASDAQ:NRIX) with a Buy and raises the price target from $19 to $26.
No Data